Washington, D.C. (June 8, 2023) – The Alliance of Community Health Plans (ACHP) is the only national payer group pushing for comprehensive drug pricing reform. Allowing Medicare to negotiate for lower prescription drug prices is an important step toward better health care for all. We reaffirm our support for the Inflation Reduction Act’s critical tools to lower drug prices for millions of Americans. Further, we continue to urge Congress to extend the Inflation Reduction Act drug pricing provisions to the commercial market.
###
About ACHP
The Alliance of Community Health Plans (ACHP) represents the nation’s top-performing nonprofit health companies, which serve tens of millions of Americans in nearly 40 states and D.C. ACHP member plans collaborate with providers on high-quality coverage and care — leading the industry in practical reforms.
ACHP is the voice of a unique payer-provider partnership model advancing proven solutions that deliver better value for patients, employers and taxpayers. Contact us for case studies and data about member innovations and results.
New from ACHP:
- ACHP Letter to Dr. Oz on Commonsense Deregulation in Medicare Advantage and Part D
- House Reconciliation Bill Brings Red Tape in the Marketplace and Leaves Millions Uninsured
- ACHP Letter to Dr. Oz on Improving Partnership Between Regional Health Plans, CMS and Maximus
- ACHP Letter on Recommendations for Anticompetitive Regulations Task Force
- ACHP Statement on the Release of the MAHA Commission Report on Childhood Chronic Disease
- ACHP Statement on Increasing Risk Adjustment Audits in Medicare Advantage
